RecruitingNot ApplicableNCT07082595

Personalized Stimulation Loop for Neurorehabilitation in Parkinson: a Proof-of-principle Study


Sponsor

University of Zurich

Enrollment

40 participants

Start Date

Jul 7, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Parkinson's disease (PD) is a neurodegenerative disease that affects about 1% of the elderly population and accounts for substantial disability and health care costs. Disability is largely driven by mobility deficits caused by impaired gait. Effective treatments are available to restore lower limb function and improve gait, but response to treatment varies greatly from patient to patient and often shows only small effect sizes. Addressing this heterogeneity requires personalization, a concept referred to precision neurorehabilitation. StimuLOOP.PD-Sleep intends to foster structured and reproducible methods for precision neurorehabilitation of gait in PD. The investigators will conduct a proof-of-concept study to investigate a sleep intervention tailored to the individual patient in the context of motor rehabilitation. • Targeted auditory stimulation during sleep (TASS): The investigators aim to reactive rehabilitation-related memories through presentation of auditory stimuli during sleep with the goal of promoting motor memory consolidation into stable motor commands. The investigators will leverage TASS to enhance consolidation of the movement patterns that are learned during rehabilitation. The investigators expect that this intervention will lead to greater gains in functional walking ability and balance. Beyond demonstrating a proof-of-concept for novel methods of applying TASS stimulation in the context of neurorehabilitation, positive results of this project may have implications for neurorehabilitation treatment in general by providing first insights into the benefits and interplay of TASS with a rehabilitation.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a personalized rehabilitation program for people with Parkinson's disease who have difficulty walking and maintaining balance. It uses a closed-loop brain stimulation system — where sensors detect movement signals from the brain and automatically adjust stimulation during physical therapy sessions — to see if it can improve gait and stability. **You may be eligible if...** - You have idiopathic Parkinson's disease (classic Parkinson's, not a variant) - You are 18 or older and have moderate problems with walking and balance (specific scoring ranges) - You are prescribed rehabilitation therapy - You are open to adjustments in your dopamine medications or deep brain stimulation (DBS) settings **You may NOT be eligible if...** - You have significant cognitive impairment (scoring below 20 on a standard memory test) - You have another neurological or medical condition causing your walking problems - You take benzodiazepines or sleep drugs that affect brain wave patterns - You had a DBS implant less than 6 months ago - You cannot walk without a walking aid Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERTASS Intervention (Sham)

Participants will sleep with the portable EEG (TSB, Axo, Tosoo AG, Zurich, CH) during 15 days of their regular motor rehabilitation. No auditory stimuli will be delivered.

OTHERTASS Intervention (Verum)

TASS: Participants will sleep with the portable EEG (TSB, Axo, Tosoo AG, Zurich, CH) during 15 days of their regular motor rehabilitation. Auditory stimuli will be delivered through the integrated headphones when non-rapid-eye-movement (NREM) sleep is detected during the night to induce TASS.


Locations(1)

University of Zurich

Zurich, Canton of Zurich, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07082595


Related Trials